Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth

Keiichi Kondo; William Y. Kim; Mirna Lechpammer; William G. Kaelin

doi:10.1371/journal.pbio.0000083

Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth

Keiichi Kondo, William Y. Kim, Mirna Lechpammer, William G. Kaelin

Research output: Contribution to journal › Article

421 Scopus citations

Abstract

Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary (VHL-associated) and sporadic clear-cell renal carcinomas as well as other abnormalities. The VHL gene product, pVHL, is part of an E3 ubiquitin ligase complex that targets the a subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for degradation in the presence of oxygen. Here we report that a HIF2α variant lacking both of its two prolyl hydroxylation/pVHL-binding sites prevents tumor inhibition by pVHL in a DNA-binding dependent manner. Conversely, downregulation of HIF2α with short hairpin RNAs is sufficient to suppress tumor formation by pVHL-defective renal carcinoma cells. These results establish that tumor suppression by pVHL is linked to regulation of HIF target genes.

Original language	English (US)
Journal	PLoS Biology
Volume	1
Issue number	3
DOIs	https://doi.org/10.1371/journal.pbio.0000083
State	Published - Jan 1 2003
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Neuroscience(all)
Biochemistry, Genetics and Molecular Biology(all)
Immunology and Microbiology(all)
Agricultural and Biological Sciences(all)

Cite this

Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003). Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth. PLoS Biology, 1(3). https://doi.org/10.1371/journal.pbio.0000083

@article{57e23abe42c247dab248bfd6cbf25a7c,

title = "Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth",

abstract = "Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary (VHL-associated) and sporadic clear-cell renal carcinomas as well as other abnormalities. The VHL gene product, pVHL, is part of an E3 ubiquitin ligase complex that targets the a subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for degradation in the presence of oxygen. Here we report that a HIF2α variant lacking both of its two prolyl hydroxylation/pVHL-binding sites prevents tumor inhibition by pVHL in a DNA-binding dependent manner. Conversely, downregulation of HIF2α with short hairpin RNAs is sufficient to suppress tumor formation by pVHL-defective renal carcinoma cells. These results establish that tumor suppression by pVHL is linked to regulation of HIF target genes.",

author = "Keiichi Kondo and Kim, {William Y.} and Mirna Lechpammer and Kaelin, {William G.}",

year = "2003",

month = jan

day = "1",

doi = "10.1371/journal.pbio.0000083",

language = "English (US)",

volume = "1",

journal = "PLoS Biology",

issn = "1544-9173",

publisher = "Public Library of Science",

number = "3",

}

TY - JOUR

T1 - Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth

AU - Kondo, Keiichi

AU - Kim, William Y.

AU - Lechpammer, Mirna

AU - Kaelin, William G.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary (VHL-associated) and sporadic clear-cell renal carcinomas as well as other abnormalities. The VHL gene product, pVHL, is part of an E3 ubiquitin ligase complex that targets the a subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for degradation in the presence of oxygen. Here we report that a HIF2α variant lacking both of its two prolyl hydroxylation/pVHL-binding sites prevents tumor inhibition by pVHL in a DNA-binding dependent manner. Conversely, downregulation of HIF2α with short hairpin RNAs is sufficient to suppress tumor formation by pVHL-defective renal carcinoma cells. These results establish that tumor suppression by pVHL is linked to regulation of HIF target genes.

AB - Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary (VHL-associated) and sporadic clear-cell renal carcinomas as well as other abnormalities. The VHL gene product, pVHL, is part of an E3 ubiquitin ligase complex that targets the a subunits of the heterodimeric transcription factor HIF (hypoxia-inducible factor) for degradation in the presence of oxygen. Here we report that a HIF2α variant lacking both of its two prolyl hydroxylation/pVHL-binding sites prevents tumor inhibition by pVHL in a DNA-binding dependent manner. Conversely, downregulation of HIF2α with short hairpin RNAs is sufficient to suppress tumor formation by pVHL-defective renal carcinoma cells. These results establish that tumor suppression by pVHL is linked to regulation of HIF target genes.

UR - http://www.scopus.com/inward/record.url?scp=85027722628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027722628&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.0000083

DO - 10.1371/journal.pbio.0000083

M3 - Article

C2 - 14691554

AN - SCOPUS:2342597973

VL - 1

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 3

ER -

Access to Document

10.1371/journal.pbio.0000083